Cytovia, Inc.
Records under this name other than patents Cytovia, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,968,595 | Substituted 4-aryl-chromene as activator of caspases and inducer of apoptosis and as antivascular agent and the use thereof Lapsed on the fee record Ended Jun 28, 2023 · USPTO record | Lapsed on the fee record | Ended Jun 28, 2023 | USPTO record |
| US 6,858,607 | 7,8-fused 4H-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof Term ended Term ended Aug 29, 2022 · USPTO record | Term ended | Term ended Aug 29, 2022 | USPTO record |
| US 6,794,400 | 4-substituted-1-(arylmethylidene)thiosemicarbazide, 4-substituted-1-(arylcarbonyl)thiosemicarbazide and analogs as activators of caspases and inducers of apoptosis and the use thereof Term ended Term ended Jul 27, 2022 · USPTO record | Term ended | Term ended Jul 27, 2022 | USPTO record |
| US 7,618,975 | 4-arylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis and the use thereof Formerly held Lapsed on the fee record Ended Nov 17, 2021 · USPTO record | Lapsed on the fee record | Ended Nov 17, 2021 | USPTO record |
| US 8,258,145 | Method of treating brain cancer Formerly held Lapsed on the fee record Ended Sep 4, 2020 · USPTO record | Lapsed on the fee record | Ended Sep 4, 2020 | USPTO record |
| US 6,248,904 | Fluorescence dyes and their applications for whole-cell fluorescence screening assays for caspases, peptidases, proteases and other enzymes and the use thereof Term ended Term ended Jul 21, 2019 · USPTO record | Term ended | Term ended Jul 21, 2019 | USPTO record |
| US 6,153,591 | Dipeptide caspase inhibitors and the use thereof Term ended Term ended Mar 16, 2019 · USPTO record | Term ended | Term ended Mar 16, 2019 | USPTO record |
| US 6,184,210 | Dipeptide apoptosis inhibitors and the use thereof Term ended Term ended Mar 16, 2019 · USPTO record | Term ended | Term ended Mar 16, 2019 | USPTO record |
| US 6,335,429 | Fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for caspases and other enzymes and the use thereof Term ended Term ended Oct 9, 2018 · USPTO record | Term ended | Term ended Oct 9, 2018 | USPTO record |
| US 7,622,497 | Derivatives of gambogic acid and analogs as activators of caspases and inducers of apoptosis Lapsed on the fee record Ended Nov 24, 2017 · USPTO record | Lapsed on the fee record | Ended Nov 24, 2017 | USPTO record |